Long-term therapy of diabetes insipidus with oral benzothiadiazine and phthalimidine diuretics.
D000284:Administration, Oral; D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001581:Benzothiadiazines / Q000008:administration & dosage*; D001786:Blood Glucose; D002648:Child; D003919:Diabetes Insipidus / Q000188:drug therapy*; D004232:Diuretics / Q000008:administration & dosage* / Q000009:adverse effects; D004357:Drug Synergism; D005260:Female; D006801:Humans; D006857:Hydroflumethiazide / Q000627:therapeutic use; D007008:Hypokalemia / Q000139:chemically induced; D007211:Indoles / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011139:Polythiazide / Q000627:therapeutic use; D011188:Potassium / Q000378:metabolism; D011719:Pyrazines / Q000627:therapeutic use; D012964:Sodium / Q000378:metabolism / Q000652:urine; D013997:Time Factors; D014223:Triamterene / Q000627:therapeutic use; D014527:Uric Acid / Q000097:blood; D014882:Water-Electrolyte Balance
D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D001786:Blood Glucose; D004232:Diuretics; D007211:Indoles; D011719:Pyrazines; D014527:Uric Acid; D011139:Polythiazide; D006857:Hydroflumethiazide; D012964:Sodium; D011188:Potassium; D014223:Triamterene